Cannabis for the treatment of amyotrophic lateral sclerosis: What is the patients’ view?
Clémence Lacroix(Inserm), Olivier Blin(Inserm), Gaëlle Bruneteau(Valve (United States)), Joëlle Micallef(Institut de Neurosciences des Systèmes), Claude Desnuelle(Centre Hospitalier Universitaire de Nice), Romain Guilhaumou(Hôpital de la Timone)
Cited by 32
Related Papers
Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia
|Nature Neuroscience|2015|782
<i>SOD1</i>, <i>ANG</i>, <i>VAPB</i>, <i>TARDBP</i>, and <i>FUS</i> mutations in familial amyotrophic lateral sclerosis: genotype–phenotype correlations
|Journal of Medical Genetics|2010|296
Causes of death in a post‐mortem series of ALS patients
|Amyotrophic Lateral Sclerosis|2008|180
Impaired glucose tolerance in patients with amyotrophic lateral sclerosis
|Amyotrophic Lateral Sclerosis|2010|173
Phenotype difference between ALS patients with expanded repeats in <i>C9ORF72</i> and patients with mutations in other ALS-related genes
|Journal of Medical Genetics|2012|173